Search results for "axis"

showing 10 items of 751 documents

Prognostic significance of the chemokine CXCL13 in node-negative breast cancer

2013

615 Background: The chemokine CXCL13 is chemotactic for B cells. We examined the prognostic significance of CXCL13 mRNA expression in node-negative breast cancer. Methods: Microarray based gene-expression data for CXCL13 (205242_at) were analysed in four previously published cohorts (Mainz, Rotterdam, Transbig, Yu) of node-negative breast cancer patients not treated with adjuvant therapy (n=824). A meta-analysis of previously published cohorts was performed using a random effects model. Prognostic significance of CXCL13 on metastasis-free survival (MFS) was examined in the whole cohort and in different molecular subtypes (ER+/HER2-, ER-/HER2-, HER2+). Independent prognostic relevance was a…

OncologyCancer Researchmedicine.medical_specialtyChemokineMicroarraybiologybusiness.industryMrna expressionObstetrics and GynecologyChemotaxismedicine.diseaseNode negativeBreast cancerOncologyInternal medicineMaternity and MidwiferyImmunologyCancer researchbiology.proteinMedicineCXCL13businessGeburtshilfe und Frauenheilkunde
researchProduct

Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors

1983

Large cooperative trials are more likely than series studied by small groups to bring about significant progress in the field of intravesical adjuvant chemotherapy of superficial bladder tumor. Multicenter randomized trials involving large numbers of patients have been conducted in Europe by the EORTC Urological Group. The Group's main objectives were to compare the efficacy of thio-TEPA, VM-26, epodyl, Adriamycin, and cisplatin, against no treatment, and to study the prophylactic effect of oral pyridoxine and evaluate the main prognostic factors. The results obtained so far are reported. Preliminary information is also given about the Blinst study, a multicenter open investigation of local…

OncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentAntineoplastic AgentsToxicologylaw.inventionRandomized controlled triallawInternal medicinemedicineCarcinomaHumansCombined Modality TherapyPharmacology (medical)DoxorubicinTeniposidePharmacologyCisplatinClinical Trials as TopicChemotherapyMulti-Institutional Systemsbusiness.industryPyridoxinePrognosismedicine.diseaseCombined Modality TherapyCarcinoma PapillaryClinical trialUrinary Bladder NeoplasmsOncologyDoxorubicinChemoprophylaxisCisplatinNeoplasm Recurrence LocalbusinessThiotepamedicine.drugCancer Chemotherapy and Pharmacology
researchProduct

Chemotherapy of bladder tumours.

1978

OncologyNephrologymedicine.medical_specialtyChemotherapyBladder cancerPapillomabusiness.industryUrologymedicine.medical_treatmentBLADDER PAPILLOMAAntineoplastic Agentsmedicine.diseaseTopical chemotherapyCarcinoma PapillaryUrinary Bladder NeoplasmsRecurrenceInternal medicineChemoprophylaxisMedicineHumansNeoplasm MetastasisbusinessCarcinoma in SituThiotepaTeniposideUrological research
researchProduct

Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Mali…

2021

Immune checkpoint inhibitors (ICI) significantly improved the prognosis of advanced melanoma patients. However, many patients do not derive long-term benefit from ICI therapy due to primary and acquired resistance. In this regard, it has been shown that coagulation factors contribute to cancer immune evasion and might therefore promote resistance to ICI. In particular, recent observations in murine systems demonstrated that myeloid-derived factor Xa (FXa) impedes anti-tumor immunity in the tumor microenvironment and that the oral FXa inhibitor (FXa-i) rivaroxaban synergizes with ICI. The synergistic effect of FXa inhibitors with clinical ICI therapy is unknown. We performed a retrospective …

Oncologyadvanced melanomaCancer Researchmedicine.medical_specialtymedicine.drug_mechanism_of_actionmedicine.medical_treatmentFactor Xa Inhibitorfactor Xa inhibitorsanti-tumor immunityArticleimmune checkpoint inhibitorsInternal medicinemedicineProgression-free survivalanticoagulationRC254-282thromboembolic eventsRivaroxabanbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancerRetrospective cohort studyImmunotherapymedicine.diseaseOncologyConcomitantimmunotherapythromboprophylaxisbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugCohort studyCancers
researchProduct

Acute stress may induce ovulation in women

2010

Abstract Background This study aims to gather information either supporting or rejecting the hypothesis that acute stress may induce ovulation in women. The formulation of this hypothesis is based on 2 facts: 1) estrogen-primed postmenopausal or ovariectomized women display an adrenal-progesterone-induced ovulatory-like luteinizing hormone (LH) surge in response to exogenous adrenocorticotropic hormone (ACTH) administration; and 2) women display multiple follicular waves during an interovulatory interval, and likely during pregnancy and lactation. Thus, acute stress may induce ovulation in women displaying appropriate serum levels of estradiol and one or more follicles large enough to respo…

OvulationHypothalamo-Hypophyseal Systemmedicine.medical_specialtyendocrine systemlcsh:QH471-489media_common.quotation_subjectPituitary-Adrenal SystemHypothalamic–pituitary–gonadal axisReviewAdrenocorticotropic hormonelcsh:Gynecology and obstetricsEndocrinologyPregnancyLactationInternal medicineFollicular phasemedicineAnimalsHumanslcsh:ReproductionGonadsOvulationlcsh:RG1-991Menstrual cyclemedia_commonbusiness.industryObstetrics and GynecologyRatsmedicine.anatomical_structureEndocrinologyReproductive MedicineAcute DiseaseFemaleAmenorrheamedicine.symptombusinessLuteinizing hormoneStress PsychologicalDevelopmental BiologyReproductive Biology and Endocrinology
researchProduct

Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort

2015

Background: Respiratory Syncytial Virus (RSV) is one of the main causes of respiratory infections during the first year of life. Very premature infants may contract more severe diseases and 'late preterm infants' may also be more susceptible to the infection. The aim of this study is to evaluate the risk factors for hospitalization during the first year of life in children born at different gestational ages in Italy. Methods: A cohort of 33-34 weeks gestational age (wGA) newborns matched by sex and age with two cohort of newborns born at 35-37 wGA and >37 wGA were enrolled in this study for a three-year period (2009-2012). Hospitalization for bronchiolitis (ICD-9 code 466.1) during the f…

PalivizumabMalePediatricsmedicine.medical_specialtyMultivariate analysisGestational AgeRespiratory Syncytial Virus InfectionsRespiratory syncytial virusPediatricsCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsRisk Factors030225 pediatricsmedicineBronchiolitis ViralHumans030212 general & internal medicineBronchiolitis; Children; Hospitalization; Palivizumab; Prophylaxis; Respiratory syncytial virus; Risk factor; Breast Feeding; Bronchiolitis Viral; Cohort Studies; Crowding; Female; Gestational Age; Hospitalization; Humans; Infant; Infant Newborn; Italy; Male; Multivariate Analysis; Respiratory Syncytial Virus Infections; Risk Factors; Sex Factors; Pediatrics Perinatology and Child HealthViralRisk factorChildrenPalivizumabBronchiolitis Hospitalization Risk factor Respiratory syncytial virus Prophylaxis Palivizumab Childrenbusiness.industryProphylaxisResearchInfant NewbornGestational ageInfantPerinatology and Child Healthmedicine.diseaseNewborn3. Good healthHospitalizationBreast FeedingCrowdingItalyBronchiolitisMultivariate AnalysisGestationBronchiolitisFemaleRisk factorbusinessBreast feedingmedicine.drugCohort study
researchProduct

Modified appleby procedure for resection of advanced pancreatic body-tail tumors with hepatic artery or celiac axis involvement

2015

Pancreatic bodymedicine.medical_specialtymedicine.anatomical_structureHepatologybusiness.industryEndocrinology Diabetes and MetabolismGastroenterologymedicineCeliac axisRadiologybusinessResectionArteryPancreatology
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct

Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: Two mixing fatal syndromes?

2012

Abstract Abnormalities in calcium and phosphorus metabolism are common and metabolic bone diseases develop often in patients with chronic renal failure (CRF). Effective clinical management includes measures to control phosphorus retention and prevent hyperphosphataemia, to maintain serum calcium concentrations within the normal range and to prevent excess parathyroid hormone (PTH) secretion by the judicious use of vitamin D sterols. Certain of these interventions, however, appear to increase the risk of soft tissue and vascular calcification in patients with End Stage Renal Disease (ESRD), so current therapeutic approaches are thus being re-evaluated in an effort to limit these risks. Patie…

Parathyroidectomymedicine.medical_specialtyPathologyCalciplhylaxisThrombotic microangiopathymedicine.medical_treatmentHemolitic Huremic SyndromeSettore MED/08 - Anatomia PatologicaGastroenterologyPhosphorus metabolismEnd stage renal diseaseInternal medicineSettore MED/35 - Malattie Cutanee E VenereemedicineHumansKidney transplantationSettore MED/14 - NefrologiaCalciphylaxisThrombotic Microangiopathiesbusiness.industryCalciphylaxisEnd Stage Renal Disease; Hemolitic Huremic Syndrome; CalciplhylaxisGeneral MedicineModels Theoreticalmedicine.diseaseKidney TransplantationSettore MED/18 - Chirurgia GeneraleSecondary hyperparathyroidismEnd Stage Renal DiseasebusinessCalcificationMedical Hypotheses
researchProduct

Antibiotic Prophylaxis for Thyroid and Parathyroid Surgery: A Systematic Review and Meta-analysis

2020

Objective: Although thyroid and parathyroid surgery is considered a clean procedure with a low incidence of surgical site infections (SSIs), a great number of endocrine surgeons use antibiotic prophylaxis (AP). The aim of this study was to assess whether AP is significantly effective in reducing the incidence of SSIs in this kind of surgery. Data Sources: A systematic literature search was performed with PubMed, Scopus, and ISI–Web of Science. Studies addressing the efficacy of AP in reducing the incidence of SSIs in thyroid and parathyroid surgery were included in the systematic review and meta-analysis. Review Methods: The random effects model was assumed to account for different sources …

Parathyroidectomymedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAntibiotics030230 surgeryparathyroidectomy03 medical and health sciences0302 clinical medicinemedicineHumansSurgical Wound InfectionEndocrine systemAntibiotic prophylaxisbusiness.industryantibiotic prophylaxisIncidence (epidemiology)ThyroidThyroidectomysurgical site infectionSurgerymedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisMeta-analysisthyroidectomySurgerybusiness
researchProduct